The drug, shown to be almost as effective as opioids for short-term pain, is the first fundamentally new kind of painkiller ...
The drug, suzetrigine, will be sold under the brand name Journavx and is the first new class of pain medicine approved in ...
The drug, suzetrigine, will be sold under the brand name Journavx and is the first new class of pain medicine approved in ...
The FDA has approved Journavx, an oral medication for treating pain that doesn't target the brain like addictive opioids.
The new non-opioid drug has been approved for the treatment of severe pain, such as that following surgery or an injury.
CNBC's Becky Quick reports on the latest news.
To help provide relief without the risk of abuse and overdoses, one pharmaceutical company is revealing its new pill designed ...
Emily Hernandez, a Missouri woman pardoned after her ties to the Jan. 6, 2021, insurrection at the U.S. Capitol, was ...
One participant in the drug trial for Journavx said it eliminated her pain without making her feel loopy or nauseous, which ...
A non-opioid pain medication made by Vertex Pharmaceuticals has received approval for adults from the Food and Drug ...
The Food and Drug Administration announced the approval of a new non-opioid pain medication this week, marking the first time ...
A new drug approved Thursday by the FDA offers pain management but is not addictive. Unlike opioids, it treats pain signals ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback